These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 7850069)
1. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast. Pagani A; Sapino A; Eusebi V; Bergnolo P; Bussolati G Virchows Arch; 1994; 425(5):459-65. PubMed ID: 7850069 [TBL] [Abstract][Full Text] [Related]
2. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836 [TBL] [Abstract][Full Text] [Related]
3. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast. Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Mazoujian G; Pinkus GS; Davis S; Haagensen DE Am J Pathol; 1983 Feb; 110(2):105-12. PubMed ID: 6130702 [TBL] [Abstract][Full Text] [Related]
5. E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast. Gupta D; Croitoru CM; Ayala AG; Sahin AA; Middleton LP Ann Diagn Pathol; 2002 Jun; 6(3):141-7. PubMed ID: 12089723 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of gross cystic disease fluid protein-15, -24 and -44 in ductal carcinoma in situ of the breast: relationship to the degree of differentiation. Selim AA; El-Ayat G; Wells CA Histopathology; 2001 Aug; 39(2):198-202. PubMed ID: 11493337 [TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation. Ansai S; Koseki S; Hozumi Y; Kondo S Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433 [TBL] [Abstract][Full Text] [Related]
8. Cytology of pleomorphic lobular carcinoma with apocrine cell differentiation of the breast. A case report. Tashiro T; Hirokawa M; Iuchi K; Emoto K; Tanaka T; Monobe Y; Sano T Acta Cytol; 2003; 47(2):265-9. PubMed ID: 12685199 [TBL] [Abstract][Full Text] [Related]
9. Spectrum of GCDFP-15 expression in human fetal and adult normal tissues. Viacava P; Naccarato AG; Bevilacqua G Virchows Arch; 1998 Mar; 432(3):255-60. PubMed ID: 9532005 [TBL] [Abstract][Full Text] [Related]
10. Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast. Honma N; Takubo K; Arai T; Younes M; Kasumi F; Akiyama F; Sakamoto G APMIS; 2006 Oct; 114(10):712-9. PubMed ID: 17004974 [TBL] [Abstract][Full Text] [Related]
11. Apocrine epithelium of the breast: does it result from metaplasia? Viacava P; Naccarato AG; Bevilacqua G Virchows Arch; 1997 Sep; 431(3):205-9. PubMed ID: 9334842 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors. Mazoujian G Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662 [TBL] [Abstract][Full Text] [Related]
13. Mitogenic effect of the 15-kDa gross cystic disease fluid protein (GCDFP-15) on breast-cancer cell lines and on immortal mammary cells. Cassoni P; Sapino A; Haagensen DE; Naldoni C; Bussolati G Int J Cancer; 1995 Jan; 60(2):216-20. PubMed ID: 7829219 [TBL] [Abstract][Full Text] [Related]
14. α-Methylacyl-CoA racemase: a useful immunohistochemical marker of breast carcinoma with apocrine differentiation. Nakamura H; Kukita Y; Kunimasa K; Kittaka N; Kusama H; Nakayama T; Tamaki Y; Sugiura R; Yasuda H; Hashimoto M; Yamamoto T; Imamura F; Nakatsuka SI Hum Pathol; 2021 Oct; 116():39-48. PubMed ID: 34314764 [TBL] [Abstract][Full Text] [Related]
15. Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic, and ultrastructural study. Eusebi V; Betts C; Haagensen DE; Gugliotta P; Bussolati G; Azzopardi JG Hum Pathol; 1984 Feb; 15(2):134-40. PubMed ID: 6365733 [TBL] [Abstract][Full Text] [Related]
16. Gross cystic disease fluid protein in nipple aspirates of breast fluid of Asian and non-Asian women. Petrakis NL; Lowenstein JM; Wiencke JK; Lee MM; Wrensch MR; King EB; Hilton JF; Miike R Cancer Epidemiol Biomarkers Prev; 1993; 2(6):573-9. PubMed ID: 8268776 [TBL] [Abstract][Full Text] [Related]
17. Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors. Mazoujian G; Bodian C; Haagensen DE; Haagensen CD Cancer; 1989 Jun; 63(11):2156-61. PubMed ID: 2655863 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue. Satoh F; Umemura S; Osamura RY Breast Cancer; 2000 Jan; 7(1):49-55. PubMed ID: 11029771 [TBL] [Abstract][Full Text] [Related]
19. Analysis of tissue- and hormone-specific regulation of the human prolactin-inducible protein/gross cystic disease fluid protein-15 gene in transgenic mice. Myal Y; Iwasiow B; Cosby H; Yarmill A; Blanchard A; Tsuyuki D; Fresnoza A; Duckworth ML; Shiu RP J Mol Endocrinol; 1998 Oct; 21(2):217-23. PubMed ID: 9801465 [TBL] [Abstract][Full Text] [Related]
20. Relation between apocrine differentiation and receptor status, prognosis and hormonal response in breast cancer. Bundred NJ; Stewart HJ; Shaw DA; Forrest AP; Miller WR Eur J Cancer; 1990; 26(11-12):1145-7. PubMed ID: 2149996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]